Skip to content

The etiology and intervention management of jining city

The etiology and intervention management of jining city

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17011486
Enrollment
Unknown
Registered
2017-05-25
Start date
2013-09-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothalamic pituitary disease

Interventions

1:recombinant human growth hormone

Sponsors

Jining Medical College Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Compared to the same age, gender, and the height of the normal child, the height of the child was below the 3rd percentile or two standard deviation; 2. Two drugs (insulin and levodopa) sequential growth hormone induced test results showed a peak < 10ng/ml; 3. There was no apparent abnormality in blood routine, liver and kidney work, lipid and thyroid function; 4. The growth rate (GV) is less than 5cm/year between 3 years and pubertas; 5. The age of bone (BA) is two years and older compared to the actual age (CA).

Exclusion criteria

Exclusion criteria: 1. The combination of other endocrine hormones to secrete the abnormality; 2. The combination of inherited metabolic diseases, bone development abnormalities, chronic diseases, and chromosomal diseases; 3. Severe malnutrition, familial idiopathic dwarfism, less than the age of a child.

Design outcomes

Primary

MeasureTime frame
height standard deviation score;

Secondary

MeasureTime frame
height;

Countries

China

Contacts

Public ContactBo Ban

Jining Medical College Affiliated Hospital

banbo2011@163.com+86 18678760007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026